Ajim Tamboli

Ajim Tamboli

Keine laufenden Positionen mehr
49 Jahre
Finance
Health Technology
Consumer Services

Profil

Ajim Akbar Tamboli is currently Chief Financial Officer at First Tracks Biotherapeutics, Inc. since 2026.
Formerly, served as Chief Financial Officer at Monte Rosa Therapeutics, Inc. from 2020 to 2023, at Rodin Therapeutics, Inc. from 2019 to 2020, and at ADARx Pharmaceuticals, Inc. Held the position of Analyst at Asymmetry Capital Management LP from 2018 to 2019 and at Columbia Management Investment Advisers LLC from 2010 to 2013.
Worked as Senior Portfolio Manager at Hovan Capital Management LLC from 2008 to 2009.
Was Research Analyst at Lehman Brothers, Inc. from 2003 to 2007 and Consultant at Duquesne Capital Management LLC in 2002.
Served as Equity Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2000 to 2001.
Also held the role of Partner & Analyst at Endurant Capital Management LP.
Education includes undergraduate degree in 1998 and graduate degree in 2002 from the University of Pennsylvania.

Aktive Positionen von Ajim Tamboli

UnternehmenPositionBeginn

Ehemalige bekannte Positionen von Ajim Tamboli

UnternehmenPositionEnde
MONTE ROSA THERAPEUTICS, INC. Finanzdirektor/CFO 08.08.2023
Finanzdirektor/CFO 01.01.2020
Analyst-Equity 01.01.2019
Analyst-Equity 01.07.2013
Analyst-Equity 01.12.2009
Sehen Sie sich die Erfahrung von Ajim Tamboli im Detail an

Ausbildung von Ajim Tamboli

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

96

Beziehungen ersten Grades

11

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen11

Finance

Finance

Finance

Finance

Consumer Services

Finance

Health Technology

Finance

Finance

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. Ajim Tamboli
-40 %: Exklusive Verlängerung
T
:
:
PROFITIEREN SIE JETZT